NFA
CLDX icon

Nationwide Fund Advisors’s Celldex Therapeutics CLDX Stock Holding History

Nationwide Fund Advisors’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,450
Closed -$320K – 408
2017
Q3 		$320K Hold
7,450
– – ﹤0.01% 2408
2017
Q2 		$276K Buy
7,450
+249
+3% +$11K ﹤0.01% 2484
2017
Q1 		$390K Sell
7,201
-1,003
-12% -$52.2K ﹤0.01% 2280
2016
Q4 		$436K Sell
8,204
-434
-5% -$24.7K ﹤0.01% 2242
2016
Q3 		$523K Sell
8,638
-947
-10% -$59K ﹤0.01% 2160
2016
Q2 		$631K Sell
9,585
-3,253
-25% -$207K ﹤0.01% 2023
2016
Q1 		$728K Buy
12,838
+5,168
+67% +$581K ﹤0.01% 1882
2015
Q4 		$1.8M Buy
7,670
+1,400
+22% +$305K 0.01% 1413
2015
Q3 		$991K Sell
6,270
-1,755
-22% -$497K ﹤0.01% 1726
2015
Q2 		$3.04M Sell
8,025
-1,303
-14% -$517K 0.01% 1205
2015
Q1 		$3.9M Buy
9,328
+2,193
+31% +$785K 0.02% 1104
2014
Q4 		$1.95M Buy
7,135
+358
+5% +$89K 0.01% 1425
2014
Q3 		$1.32M Buy
6,777
+7
+0.1% +$1.52K 0.01% 1684
2014
Q2 		$1.66M Buy
6,770
+854
+14% +$193K 0.01% 1579
2014
Q1 		$1.57M Sell
5,916
-180
-3% -$68.9K 0.01% 1508
2013
Q4 		$2.21M Sell
6,096
-1,226
-17% -$472K 0.01% 1399
2013
Q3 		$3.89M Buy
7,322
+85
+1% +$29.1K 0.02% 1048
2013
Q2 		$1.7M Buy
+7,237
New +$1.42M 0.01% 1391

Other funds holding CLDX

CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KE
KLP Enterprises Branford, Connecticut $1.97M AUM
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nationwide Fund Advisors's CLDX Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Celldex Therapeutics (CLDX) in Q4 2017, closing a stake of 7,450 shares — an estimated $320K sold.

Nationwide Fund Advisors first reported a position in CLDX in Q2 2013 and held it in 18 quarters. The position peaked at $3.9M in Q1 2015. 135 funds tracked by Wall St. Rank hold CLDX as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Celldex Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 7,450 Celldex Therapeutics shares in Q4 2017, an estimated $320K.
  • Nationwide Fund Advisors first reported a position in Celldex Therapeutics in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Celldex Therapeutics position peaked at $3.9M in Q1 2015.
  • 135 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.